drug marketing lawsuit News

Indivior to Pay $600M to Settle Claims of Deceptive Marketing of Opioid Treatment

Indivior Plc has agreed to pay $600 million and have a subsidiary plead guilty to a felony charge to resolve U.S. allegations that it engaged in an illegal scheme to boost prescriptions of its opioid addiction treatment Suboxone. The U.S. …

South Carolina High Court Further Reduces Penalty on Janssen Pharmaceuticals

South Carolina’s highest court further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug. The decision was to substitute the same verdict the court reached in February in order to correct a …